Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Should induction therapy with high-dose glucocorticoids be the standard treatment for all patients with giant cell arteritis?

Nature Clinical Practice Rheumatology volume 3, pages 132–133 (2007)Cite this article

boxed-textMazlumzadeh M et al. (2006) Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial. Arthritis Rheum 54: 3310–3318

Further study of induction therapy with high-dose corticosteroids in patients with giant cell arteritis is warranted, but it should not become standard treatment at the current time

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Aiello PD et al. (1993) Visual prognosis in giant cell arteritis. Ophthalmology 100: 550–555

    Article  CAS  Google Scholar 

  2. Seo P and Stone JH (2004) Large-vessel vasculitis. Arthritis Rheum 51: 128–139

    Article  Google Scholar 

  3. Moses RE et al. (1981) Fatal arrhythmia after pulse methylprednisolone therapy. Ann Intern Med 95: 781–782

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Murphy, Assistant Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. CA Langford is the Director of the Center for Vasculitis Care and Research and GS Hoffman is a Professor and the Harold C Schott Chair of Rheumatic and Immunologic Diseases at the Cleveland Clinic Foundation, Lerner College of Medicine, Cleveland, OH, USA.,

    Carol A Langford & Gary S Hoffman

Authors
  1. Carol A Langford
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gary S Hoffman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gary S Hoffman.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Langford, C., Hoffman, G. Should induction therapy with high-dose glucocorticoids be the standard treatment for all patients with giant cell arteritis?. Nat Rev Rheumatol 3, 132–133 (2007). https://doi.org/10.1038/ncprheum0425

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncprheum0425

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing